Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
November 14, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce very positive...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Reports Progress on Collaboration with Noria Pharmaceuticals
October 15, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce the successful...
Advanced Proteome logo.jpg
APC Comments on Favorable Results in Initial Animal Studies
October 09, 2018 09:00 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to report favorable results in...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
September 13, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to report significant progress...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Provides Overview of Current Activities and Strategic Objectives
September 11, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to provide an overview of...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement
August 23, 2018 17:30 ET | Advanced Proteome Therapeutics Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) --  Advanced Proteome Therapeutics Corporation...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Announces Non-Brokered Private Placement
August 03, 2018 16:00 ET | Advanced Proteome Therapeutics Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) --  Advanced Proteome Therapeutics Corporation...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals
July 17, 2018 09:03 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to announce the collaboration of...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Advances its Technological Capability
June 18, 2018 08:30 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8), is pleased to report continuing progress on...
Advanced Proteome logo.jpg
Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director
June 06, 2018 17:05 ET | Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointment of Mr....